US 7,744,880 B2Granted

Cell growth inhibitors containing anti-glypican 3 antibody

AssigneeChugai Seiyaku Kabushiki Kaisha

InventorsHiroyuki Aburatani, Tetsuo Nakamura, Masayuki Tsuchiya

Life of this patent

Estimating the term…

Abstract

Provided is a cell growth inhibitor that can be used for treating diseases based on abnormal cell proliferation, and in particular cancer. The cell growth inhibitor contains an anti-glypican 3 antibody as an active ingredient.

Claims4

Dependent claims

A method of treating hepatic cancer comprising administering to a patient in need thereof a pharmaceutical composition containing an anti-glypican 3 antibody as an active ingredient.

Dependencies are inferred from the claim text.

Facts

Application: 11/702,780Filed 5 Feb 2007 · continuation
Priority: JP 2001-18944322 Jun 2001
Published: US 2007/0172488 A126 Jul 2007
Granted: 29 Jun 2010
Term ends: Not estimatedThe source records don’t support an estimate.

Classification15 codes

C07K 16/28
Against material from animals or humans: against receptors, cell surface antigens or cell surface determinants
A61P 1/16
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
A61P 35/00
Antineoplastic agents
A61P 35/02
Antineoplastic agents: specific for leukemia

Family

PCT/JP02/06237Parent of this continuation · filed 21 Jun 2002
US 2007/0172488 A1Pre-grant publication · published 26 Jul 2007
Application10/481,524Parent of this continuation
US 2004/0236080 A1Published application
US 7,744,880 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results